These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 23772771)

  • 1. Immunological abnormalities associated with hereditary haemorrhagic telangiectasia.
    Guilhem A; Malcus C; Clarivet B; Plauchu H; Dupuis-Girod S
    J Intern Med; 2013 Oct; 274(4):351-62. PubMed ID: 23772771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pro-angiogenic changes of T-helper lymphocytes in hereditary hemorrhagic telangiectasia.
    Guilhem A; Ciudad M; Aubriot-Lorton MH; Greigert H; Cladière C; Leguy-Seguin V; Audia S; Samson M; Bonnotte B
    Front Immunol; 2023; 14():1321182. PubMed ID: 38143764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seven cases of hereditary haemorrhagic telangiectasia-like hepatic vascular abnormalities associated with
    Guilhem A; Dupuis-Girod S; Espitia O; Rivière S; Seguier J; Kerjouan M; Lavigne C; Maillard H; Magro P; Alric L; Lipsker D; Parrot A; Leguy V; Vanlemmens C; Guibaud L; Vikkula M; Eyries M; Valette PJ; Giraud S
    J Med Genet; 2023 Sep; 60(9):905-909. PubMed ID: 36813543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4+ T-lymphopenia in HIV negative tuberculous patients at King Khalid University Hospital in Riyadh, Saudi Arabia.
    Al-Aska A; Al-Anazi AR; Al-Subaei SS; Al-Hedaithy MA; Barry MA; Somily AM; Buba F; Yusuf U; Al Anazi NA
    Eur J Med Res; 2011 Jun; 16(6):285-8. PubMed ID: 21810564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved survival outcomes in cancer patients with hereditary hemorrhagic telangiectasia.
    Duarte CW; Murray K; Lucas FL; Fairfield K; Miller H; Brooks P; Vary CPH
    Cancer Epidemiol Biomarkers Prev; 2014 Jan; 23(1):117-125. PubMed ID: 24192008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The bleeding diathesis in patients with hereditary haemorrhagic telangiectasia is not due to impaired platelet function.
    Lyster AL; Biørn SH; Kjeldsen AD; Nielsen C; Lange B; Fialla AD; Vinholt PJ
    Orphanet J Rare Dis; 2023 Nov; 18(1):354. PubMed ID: 37964294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unsupervised machine learning algorithms identify expected haemorrhage relationships but define unexplained coagulation profiles mapping to thrombotic phenotypes in hereditary haemorrhagic telangiectasia.
    Mukhtar G; Shovlin CL
    EJHaem; 2023 Aug; 4(3):602-611. PubMed ID: 37601877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss-of-Function in SMAD4 Might Not Be Critical for Human Natural Killer Cell Responsiveness to TGF-β.
    Healy LP; Rossi GR; Rautela J; Slade CA; Huntington ND; Winship IM; Souza-Fonseca-Guimaraes F
    Front Immunol; 2019; 10():904. PubMed ID: 31118932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mulibrey nanism and immunological complications: a comprehensive case report and literature review.
    Gazzin A; Pala F; Bosticardo M; Niemela J; Stoddard J; Biasin E; Quarello P; Carli D; Ferroni F; Delmonte OM; Montin D; Rosenzweig SD; Licciardi F; Notarangelo LD
    Front Immunol; 2023; 14():1303251. PubMed ID: 38116000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and risk factors for bleeding in hereditary hemorrhagic telangiectasia: a National Inpatient Sample study.
    Zarka J; Jeong K; Yabes JG; Ragni MV
    Blood Adv; 2023 Oct; 7(19):5843-5850. PubMed ID: 37567149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevalencia de la Telangiectasia Hemorrágica Hereditaria: estudio de base poblacional en la Comunitat Valenciana (España).].
    de la Natividad Palomares M; Barrachina-Bonet L; García-Villodre L; Guardiola-Vilarroig S; Zurriaga Llorens Ó; Cavero-Carbonell C
    Rev Esp Salud Publica; 2023 Nov; 97():. PubMed ID: 37970896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe combined immunodeficiency caused by inositol-trisphosphate 3-kinase B (ITPKB) deficiency.
    Almutairi A; Wallace JG; Jaber F; Alosaimi MF; Jones J; Sallam MTH; Elnagdy MH; Chou J; Sobh A; Geha RS
    J Allergy Clin Immunol; 2020 Jun; 145(6):1696-1699.e6. PubMed ID: 31987846
    [No Abstract]   [Full Text] [Related]  

  • 13. Hereditary hemorrhagic telangiectasia: from signaling insights to therapeutic advances.
    Al Tabosh T; Al Tarrass M; Tourvieilhe L; Guilhem A; Dupuis-Girod S; Bailly S
    J Clin Invest; 2024 Feb; 134(4):. PubMed ID: 38357927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tacrolimus as a Promising Drug for Epistaxis and Gastrointestinal Bleeding in HHT.
    Álvarez-Hernández P; Patier JL; Marcos S; Gómez Del Olmo V; Lorente-Herraiz L; Recio-Poveda L; Botella LM; Viteri-Noël A; Albiñana V
    J Clin Med; 2023 Nov; 12(23):. PubMed ID: 38068462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifocal Abscesses, Necrotizing Fasciitis, Iron Deficiency Anemia, and Hypophosphatemia Induced by Ferric Carboxymaltose Infusions: Report of a Case of Hereditary Hemorrhagic Telangiectasia.
    Trevise LA; Lopes Vieira Pinto MP; Hasselmann G; Lammoglia BC; Leal TP; Salles Rosa Neto N
    Cureus; 2023 Aug; 15(8):e44020. PubMed ID: 37746404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor Improves Leukocyte Energy Metabolism in Hereditary Hemorrhagic Telangiectasia.
    Schild Y; Bosserhoff J; Droege F; Littwitz-Salomon E; Fandrey J; Wrobeln A
    Life (Basel); 2023 Aug; 13(8):. PubMed ID: 37629565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infective endocarditis with Osler's nodule in a patient with Osler's disease: a case report and review of the literature.
    Naruse G; Watanabe T; Okura H
    J Med Case Rep; 2022 May; 16(1):211. PubMed ID: 35643752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered hypoxia inducible factor regulation in hereditary haemorrhagic telangiectasia.
    Wrobeln A; Leu T; Jablonska J; Geisthoff U; Lang S; Fandrey J; Droege F
    Sci Rep; 2022 Apr; 12(1):5877. PubMed ID: 35393474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent erysipelas led to diagnosis of hereditary hemorrhagic telangiectasia.
    Yamaoka M; Kanzawa Y; Tatehara S; Sasaki K; Mizuki S; Ohnishi J; Nakajima T; Ishimaru N; Kinami S
    Infez Med; 2022; 30(1):129-133. PubMed ID: 35350259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered expressions of CXCR4 and CD26 on T-helper lymphocytes in hereditary hemorrhagic telangiectasia.
    Guilhem A; Portalès P; Dupuis-Girod S; Rivière S; Vincent T
    Orphanet J Rare Dis; 2021 Dec; 16(1):511. PubMed ID: 34906163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.